GLP-1 Weight Management

GLP-1 agonists mimic natural gut hormones to aid weight loss and stabilize blood sugar by reducing hunger, stimulating insulin, and slowing gastric emptying.

Approved by the FDA for type 2 diabetes and obesity, common patented drugs include Mounjaro (Tirzepatide), Rybelsus (Semaglutide, oral), Wegovy (Semaglutide for weight loss), and Ozempic (Semaglutide for diabetes).

We offer generic versions of these GLP-1 drugs with the same proven efficacy at more affordable prices, helping you manage your health without high costs.

猛健樂（Mounjaro）

Generic Mounjaro

Tirzepatide

Product Introduction:Developed by Eli Lilly, this dual GIP and GLP-1 agonist is the most effective GLP-1 weight-loss drug, with 22.5% average weight reduction after 72 weeks.

Generic Drug Name:Tizaro

Medication Frequency:Once a week

Learn More

Generic Rybelsus

Semaglutide (Oral)

Product Introduction:An oral hypoglycemic drug developed by the Danish pharmaceutical company Novo Nordisk, featuring the advantages of being storable at room temperature and not requiring injections. However, its weight loss effect is inferior to the injectable version.

Generic Drug Name:Semaglo

Medication Frequency:Once a day

Learn More

Generic Wegovy

Semaglutide (Weight loss)

Drug Introduction:Developed by Denmark's Novo Nordisk, it is the world's first GLP-1 weight loss drug approved by the US FDA. Clinical trials have shown it can reduce body weight by approximately 12-15%.

Generic Drug Name:Semaglo OB

Medication Frequency:Once a week

Learn More

Generic Ozempic

Semaglutide (Diabetes)

Product Introduction:An injectable hypoglycemic drug developed by the Danish pharmaceutical company Novo Nordisk, with the same ingredients as the weight loss version. The maximum dose of the diabetes version is only 0.5mg, while the maximum dose of the weight loss version is 2.4mg.

Generic Drug Name:Semaglo Inj

Medication Frequency:Once a week

Learn More

GLP-1 Introduction

1 3